0001179110-18-001372.txt : 20180201 0001179110-18-001372.hdr.sgml : 20180201 20180201174703 ACCESSION NUMBER: 0001179110-18-001372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180130 FILED AS OF DATE: 20180201 DATE AS OF CHANGE: 20180201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ford Robert B CENTRAL INDEX KEY: 0001612571 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 18567913 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2018-01-30 0 0000001800 ABBOTT LABORATORIES ABT 0001612571 Ford Robert B 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive Vice President Common shares without par value 2018-01-30 4 M 0 4467 26.1879 A 56633 D Common shares without par value 2018-01-30 4 M 0 10400 22.3919 A 67033 D Common shares without par value 2018-01-30 4 M 0 19600 27.0336 A 86633 D Common shares without par value 2018-01-30 4 M 0 49000 34.94 A 135633 D Common shares without par value 2018-01-30 4 S 0 200 62.81 D 135433 D Common shares without par value 2018-01-30 4 S 0 300 62.82 D 135133 D Common shares without par value 2018-01-30 4 S 0 100 62.825 D 135033 D Common shares without par value 2018-01-30 4 S 0 527 62.83 D 134506 D Common shares without par value 2018-01-30 4 S 0 100 62.84 D 134406 D Common shares without par value 2018-01-30 4 S 0 200 62.845 D 134206 D Common shares without par value 2018-01-30 4 S 0 100 62.85 D 134106 D Common shares without par value 2018-01-30 4 S 0 100 62.86 D 134006 D Common shares without par value 2018-01-30 4 S 0 400 62.88 D 133606 D Common shares without par value 2018-01-30 4 S 0 200 62.89 D 133406 D Common shares without par value 2018-01-30 4 S 0 200 62.8975 D 133206 D Common shares without par value 2018-01-30 4 S 0 100 62.90 D 133106 D Common shares without par value 2018-01-30 4 S 0 200 62.91 D 132906 D Common shares without par value 2018-01-30 4 S 0 200 62.93 D 132706 D Common shares without par value 2018-01-30 4 S 0 1100 62.95 D 131606 D Common shares without par value 2018-01-30 4 S 0 200 62.955 D 131406 D Common shares without par value 2018-01-30 4 S 0 2700 62.96 D 128706 D Common shares without par value 2018-01-30 4 S 0 200 62.965 D 128506 D Common shares without par value 2018-01-30 4 S 0 2000 62.97 D 126506 D Common shares without par value 2018-01-30 4 S 0 400 62.975 D 126106 D Common shares without par value 2018-01-30 4 S 0 1000 62.98 D 125106 D Common shares without par value 2018-01-30 4 S 0 1346 62.985 D 123760 D Common shares without par value 2018-01-30 4 S 0 100 62.9875 D 123660 D Common shares without par value 2018-01-30 4 S 0 3600 62.99 D 120060 D Common shares without par value 2018-01-30 4 S 0 5303 62.995 D 114757 D Common shares without par value 2018-01-30 4 S 0 21789 63 D 92968 D Option (right to buy) 26.1879 2018-01-30 4 M 0 4467 0 D 2013-02-19 2020-02-18 Common shares 4467 0 D Option (right to buy) 22.3919 2018-01-30 4 M 0 10400 0 D 2014-02-18 2021-02-17 Common shares 10400 0 D Option (right to buy) 27.0336 2018-01-30 4 M 0 19600 0 D 2015-02-17 2022-02-16 Common shares 19600 0 D Option (right to buy) 34.94 2018-01-30 4 M 0 49000 0 D 2016-02-15 2023-02-14 Common shares 49000 0 D Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 1 of 2. John A. Berry, by power of attorney for Robert B. Ford 2018-02-01